Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
nrvHf0JPvGvaR5ub